Nabriva Therapeutics PLC (NASDAQ:NBRV)

Delayed Data
As of Feb 25
 -0.07 / -4.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 6.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +360.99% increase from the last price of 1.41.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nabriva Therapeutics PLC. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.33%
Growthannually 49.24%


Growthquarterly -73.59%
Growthannually 9.46%
Key to the earnings and sales forecast charts.